Highly specific tumor binding of a 213bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional α-radioimmunotherapy of diffuse-type gastric cancer

Cancer Research

Volumn 61, Issue 7, 2001, Pages 2804-2808

  Senekowitsch Schmidtke, Reingard ^a   Schuhmacher, Christoph ^a   Becker, Karl Friedrich ^a,b   Nikula, Tuomo K ^c   Seidl, Christof ^a   Becker, Ingrid ^a   Miederer, Matthias ^a   Apostolidis, Christos ^c   Adam, Christoph ^a   Huber, Roswitha ^a   Kremmer, Elisabeth ^b   Fischer, Kathrin ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Institute of Soil Ecology   (United Kingdom)

^c Institute for Transuranium Elements   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; MONOCLONAL ANTIBODY BI 213; UNCLASSIFIED DRUG; UVOMORULIN;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; AUTORADIOGRAPHY; BINDING AFFINITY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG BINDING; FEMALE; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; STOMACH CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BISMUTH; CADHERINS; FEMALE; HUMANS; IMMUNOTOXINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MUTATION; RADIOIMMUNOTHERAPY; RADIOISOTOPES; STOMACH NEOPLASMS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035300544     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII
2. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-Succinimidyl 5-iodo-3-pyridinecarboxylate
3. 211At]Astato-3-pyridinecarboxylate
4. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
5. Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion, and increase cellular motility
6. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody
7. An effective chelating agent for labeling of monoclonal antibody with Bi-212 for α-particle mediated radioimmuno-therapy
8. α-Emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: Pharmacokinetics, bioactivity, toxicity, and chemistry
9. A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies
10. Production of Ac-225 and application of the Bi-213 daughter in cancer therapy
11. Effective α-particle-mediated radioimmunotherapy of murine leukemia
12. 90Y-labeled CO17-1A Fab fragments in a human colonic cancer model
13. 90Y targeted to blood vessels: Comparison with the α-particle emitter 213Bi
14. 90Y) colloids in mice
15. 211At-labeled monoclonal antibody MOv18
16. Astatine-211-labeled radiotherapeutics: An emerging approach to targeted α-particle radiotherapy
17. Microdosimetric concepts in radioimmunotherapy
18. Dosimetric framework for therapeutic α-particle emitters
19. The cytotoxicity and microdosimetry of Astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro
20. Radioimmunotherapy with α-emitting nuclides